Garcia-Manero, G <br/><br/>
The hyper-CVAD regimen in adult acute lymphocytic leukemia.  [electronic resource] 

 -  Hematology/oncology clinics of North America  Dec 2000 
 - 1381-96, x-xi p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0889-8588 
<br/><br/><label>Standard No.: </label>10.1016/s0889-8588(05)70192-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Infective Agents--administration & dosage<br/>Antibiotic Prophylaxis<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers, Tumor<br/>Central Nervous System Neoplasms--prevention & control<br/>Child<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Immunization, Passive<br/>Immunophenotyping<br/>Infusions, Intravenous<br/>Injections, Spinal<br/>Karyotyping<br/>Mercaptopurine--administration & dosage<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Philadelphia Chromosome<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--administration & dosage<br/>Remission Induction<br/>Risk<br/>Rituximab<br/>Survival Analysis<br/>Texas--epidemiology<br/>Treatment Outcome<br/>Vincristine--administration & dosage